Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
ANG LIFESCIENCES INDIA LIMITED |
End-of-day quote
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 64.69 INR | +0.90% | +1.51% | -46.16% | |
| Oct. 16 | ANG Lifesciences India CFO Steps Down | MT |
| Oct. 14 | ANG Lifesciences India Limited Announces Resignation of Neeraj Gupta as Chief Financial Officer | CI |
| Sales 2023 | 2.2B 26.36M | Sales 2024 * | - | Capitalization | 993M 11.9M |
|---|---|---|---|---|---|
| Net income 2023 | -2M -23.97K | Net income 2024 * | - | EV / Sales 2023 | 0,75x |
| Net Debt 2023 | 666M 7.98M | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
| P/E ratio 2023 | -377x | P/E ratio 2024 * | Employees | 545 | |
| Yield 2023 | - | Yield 2024 * |
-
| Free-Float | 29.4% |
More Fundamentals
* Assessed data
More news
More recommendations
| 1 day | +0.90% | ||
| 1 week | +1.51% | ||
| Current month | +1.06% | ||
| 1 month | -5.93% | ||
| 3 months | -13.72% | ||
| 6 months | -10.87% | ||
| Current year | -46.16% |
1 week
62.49
65.88
1 month
61.9971.59
Current year
52.10124.80
1 year
52.10143.00
3 years
28.60640.36
5 years
10.62640.36
10 years
10.62640.36
| Managers | Title | Age | Since |
|---|---|---|---|
Rajesh Gupta
FOU | Founder | 51 | 2016 |
Renu Kaur
CMP | Compliance Officer | 31 | 2021 |
Satish Mahajan
ADM | Chief Administrative Officer | - | 2013 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Rajesh Gupta
FOU | Founder | 51 | 2016 |
Saruchi Gupta
BRD | Director/Board Member | 75 | 2011 |
Pawanjit Singh
BRD | Director/Board Member | 55 | 2016 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-12-03 | 64.69 | +0.90% | 5 510 |
| 23-12-01 | 64.11 | +0.16% | 11,883 |
| 23-11-30 | 64.01 | +1.51% | 4,129 |
| 23-11-29 | 63.06 | -2.23% | 10,635 |
| 23-11-28 | 64.5 | +1.21% | 7,826 |
End-of-day quote Bombay Stock Exchange, December 03, 2023
More quotes
ANG Lifesciences India Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials. It operates in two segments, namely pharmaceuticals and printing and packagings. The Company's products portfolio includes various products comprising therapeutic categories, such as Antibiotics, Antiviral, Antimalarial, Antiulcer, Carbapenem, Corticosteroid, Penicillin and Beta Lactamase Inhibitor. It is engaged in the business of manufacturing and sales of finished pharmaceutical formulations in a dosage form of Dry Powder Injection Vials, Liquid Injections Vials, Ampoules, PFS, Hard Gelatin Capsules, Tablets, Soft Gelatin Capsules, Dry Syrups, Liquid Syru ps and Suspension, and Lotions, among others. The Company's subsidiaries include ANG Lifesciences India Limited and Mansa Prints and Publishers Limited.
Sector
Pharmaceuticals
Calendar
2024-02-12
- Q3 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -46.16% | 10 M $ | |
| +59.46% | 525 B $ | |
| +47.59% | 454 B $ | |
| -9.88% | 381 B $ | |
| -5.25% | 262 B $ | |
| -10.25% | 253 B $ | |
| -15.11% | 221 B $ | |
| +3.11% | 202 B $ | |
| -8.45% | 200 B $ | |
| -42.47% | 163 B $ |
